As of December 2024, TG Therapeutics has a market cap of $4.88B. This makes TG Therapeutics the world's 2746th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.15B | -16.92% |
2023 | $2.59B | 44.38% |
2022 | $1.79B | -37.74% |
2021 | $2.88B | -63.48% |
2020 | $7.88B | 368.65% |
2019 | $1.68B | 170.73% |
2018 | $620.78M | -50.00% |
2017 | $1.24B | 76.34% |
2016 | $704.06M | -61.02% |
2015 | $1.81B | -24.68% |
2014 | $2.40B | 306.15% |
2013 | $590.50M | 7.14% |
2012 | $551.13M | 223.56% |
2011 | $170.34M | -97.78% |
2010 | $7.67B | - |